Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility
- 31 October 2019
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 500, 233-240
- https://doi.org/10.1016/j.cca.2019.10.023
Abstract
No abstract availableKeywords
Funding Information
- Spanish Ministry of Economy and Competitiveness
- FEDER
This publication has 54 references indexed in Scilit:
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsPLOS ONE, 2013
- Plasma choline and betaine correlate with serum folate, plasma S-adenosyl-methionine and S-adenosyl-homocysteine in healthy volunteerscclm, 2013
- Metabolite Profiling of Alzheimer's Disease Cerebrospinal FluidPLOS ONE, 2012
- Quantification of acetylcholine, choline, betaine, and dimethylglycine in human plasma and urine using stable-isotope dilution ultra performance liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2010
- The clinical use of structural MRI in Alzheimer diseaseNature Reviews Neurology, 2010
- Modulation of cholinergic functions by serotonin and possible implications in memory: General data and focus on 5-HT1A receptors of the medial septumBehavioural Brain Research, 2008
- Uridine and cytidine in the brain: Their transport and utilizationBrain Research Reviews, 2006
- The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical ValidityJournal of Clinical and Experimental Neuropsychology, 1998
- CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patientsActa Neurologica Scandinavica, 1989
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982